5th International Conference of FFC
Functional Foods for Chronic Diseases: Obesity and Other Related Chronic Diseases
October 16–18, 2008, Southern University, Baton Rouge, Louisiana, USA
|
|
|
DEAR COLLEAGUES:
We are very pleased to announce the 5th International Conference “Functional Foods for Chronic Diseases.” The conference will bring together experts in medicine, biology, and the food industry to discuss the contribution of functional foods in the prevention and treatment of Chronic Diseases. The conference will cover the advances of phytotherapy and food therapy of obesity and other related chronic diseases (cardiovascular diseases, diabetes, and others), with a special focus on the creation of functional and medicinal foods with new properties.
Main Conference Topics:
1. The role of nutrition in obesity occurrence.
2. The creation of functional and medicinal products for the prevention and treatment of obesity and other obesity related diseases (cardiovascular diseases, diabetes, and more).
For preliminary list of topics, click here.
PAPER REGISTRATION AND SUBMISSION:
The deadline for contributions is October 16, 2008, to submit manuscripts to the organizers. Early submissions are encouraged. The deadline for abstracts is September 1, 2008. Decisions on selection will be communicated to the authors by e-mail. All contributions will be reviewed, but a limited number will be selected for the proceedings. For any information concerning publications, please contact us at ffc_usa@sbcglobal.net.
COPIES FOR CONTRIBUTORS:
We will furnish one copy of the collective work without charge to the lead author of the article (Editor: Danik M. Martirosyan, Ph.D)
GUIDANCE FOR AUTHORS:
The best way to send in your contributions is by email, as an attached file. Our preferred word-processing format is Microsoft Word, version 6. Manuscripts must be single-spaced, in 12-point font (including the references and legends of tables and figures) on sheets of uniform size (preferably ISO A4) with wide margins. A title of up to 10 words (in uppercase), and the first and last name of the author, department, and organization address should also appear. If there is more than one establishment involved in the work, authors' names should be linked to the appropriate establishment by the use numbers and the symbols *, †, ‡, §, and ¶ in that order. A summary giving a bulleted outline of content should appear for the introduction.
If there are any abbreviations in your article, they should be placed in brackets after the full title on the first occasion they are used.
The main body of the paper should be divided into: (a) introduction; (b) experimental, including materials and methods; (c) results, with appropriate quantification and statistical treatment of data; (d) tables and figures; (e) discussion (f) acknowledgements, including details of financial support; (g) numbered references. It is often an advantage to combine (c), (d) and (e) to gain conciseness and clarity. The discussion section should not recapitulate the results; only discuss their implications. The number of references should not normally exceed 50, and 20–30 references are frequently adequate.
REFERENCES:
References in the paper must be numbered in the order in which they appear in the text. The list of references at the end of the paper should give all the authors' names and initials unless there are more than 6 authors, in which case 'et al' is used for subsequent names. This is followed by the title, abbreviated according to the "List of Journals Indexed" in Index Medicus, the year of publication, the volume number, and the first and last page numbers. References to books should give the names of any editors, place of publication, publisher and year, in place of the journal information.
HOTEL INFORMATION:
Rooms have been reserved with the Hilton Gardon Inn for the Octoberber 16-18 conference for a special rate of US $85+ tax, per night. This rate will be available until September 16th, 2008. To make a reservation, please call (225)-357-6725 and be sure to mention the "Functional Foods for Chronic Diseases", to get the special rate.
HOTEL LOCATION:
For more information on the conference, contact Dr. Danik Martirosyan at ffc_usa@sbcglobal.net. For international calls, please use 469-441-8272.
Hilton Gardon Inn
3330 Harding Blvd
Baton Rouge, La 70807
Phone: 225-357-6725
Fax: 225-357-6175 Fax
DEAR COLLEAGUES:
We are very pleased to announce the 5th International Conference “Functional Foods for Chronic Diseases.” The main goal of the Conference is to bring together experts in medicine, biology, and the food industry to discuss the contribution of functional foods in the prevention and treatment of Chronic Diseases. The scope of the Conference will cover the advances of phytotherapy and food therapy of obesity and other related chronic diseases (cardiovascular diseases, diabetes, and others), with a special focus on the creation of functional and medicinal foods with new properties.
Main Conference Topics:
1. The role of nutrition in obesity occurrence.
2. The creation of functional and medicinal products for the prevention and treatment of obesity and other obesity related diseases (cardiovascular diseases, diabetes, and more).
For preliminary list of topics click here.
REGISTRATION AND SUBMITTING OF PAPERS:
The deadline for contributions is October 16, 2008 to submit manuscripts to the organizers. Early submissions are encouraged. The deadline for abstracts is September 1, 2008. Decisions on selection will be promptly communicated to the authors by E-mail. All contributions will be reviewed but a limited number will be selected for the proceedings. For any information concerning publications please contact us at ffc_usa@sbcglobal.net
COPIES FOR CONTRIBUTORS:
We will furnish one copy of the collective work without charge to the lead author of the article (Editor: Danik M. Martirosyan, Ph.D)
GUIDANCE FOR AUTHORS:
The best way to send in your contributions is by email as an attached file. Our preferred word-processing format is Microsoft Word, version 6. Manuscripts must be single-spaced, in 12 point typeface (including the references and legends of tables and figures) on sheets of uniform size (preferably ISO A4) with wide margins. A title of up to ten words (in uppercase), and the first and last name of the author, department, and organization address should also appear. If there is more than one establishment involved in the work, authors' names should be linked to the appropriate establishment by the use numbers and the symbols *, †, ‡, §, and ¶ in that order. A summary giving a bulleted outline of content should appear for the introduction.
If there are any abbreviations in your article, they should be placed in brackets after the full title on the first occasion they are used.
The main body of the paper should be divided into: (a) introduction; (b) experimental, including materials and methods; (c) results, with appropriate quantification and statistical treatment of data; (d) tables and figures; (e) discussion (f) acknowledgements, including details of financial support; (g) numbered references. It is often an advantage to combine (c), (d) and (e) to gain conciseness and clarity. The discussion section should not recapitulate the results, but only discuss their implications. The number of references should not normally exceed 50, and 20–30 references are frequently adequate
REFERENCES:
References in the paper must be numbered in the order in which they appear in the text. The list of references at the end of the paper should give all the author's names and initials unless there are more than six authors, in which case 'et al' is used for subsequent names. This is followed by the title, abbreviated according to the "List of Journals Indexed" in Index Medicus, the year of publication, the volume number, and the first and last page numbers. References to books should give the names of any editors, place of publication, publisher and year, in place of the journal information.
HOTEL INFORMATION:
Rooms have been reserved with the Hilton Gardon Inn for the Octoberber 16-18 conference for a special rate of US $85+ tax, per night. This rate will be available until September 16th, 2008. To make a reservation, please call (225)-357-6725 and be sure to mention the " Functional Foods for Chronic Diseases " to get the special rate.
HOTEL LOCATION:
For more information on the conference, contact Dr. Danik Martirosyan at ffc_usa@sbcglobal.net. For international calls, please use 469-441-8272.
Hilton Gardon Inn
3330 Harding Blvd
Baton Rouge, La 70807
Phone: 225-357-6725
Fax: 225-357-6175 Fax
|
|
|
Conference Program
|
Thursday, October 16, 2008 |
|
8:30 a.m.
|
Conference Registration
|
|
|
Chairing: Fatemeh Malekian , PhD, Associate Professor, Food Science and Nutrition, Southern University, Agricultural Research and Extension Center, Baton Rouge, LA, USA
|
|
9:30 a.m.
|
Welcome to Southern University Agricultural Research and Extension Center, Baton Rouge, LA
Dr. Leodrey Williams, Chancellor of SU Agricultural Research and Extension Center
Dr. Kirkland Mellad, Vice Chancellor for Research, Agricultural Research and Extension Center
Dr. Gina E. Eubanks, Vice Chancellor of Extension, SU Agricultural Research and Extension Center
|
|
10:00-10:30 a.m.
|
Introduction of Functional and Healthy Foods for Chronic Diseases
Danik M. Martirosyan, PhD, Chairmen of Conference, Founder of Functional Foods Center at D&A Inc. Dallas, TX, USA
|
|
10:30-11:30 a.m.
|
Current Concepts in Obesity and Their Relevance to Newer Approaches to its Management
Undurti N Das, MD, President of Biotech Company, UND Life Sciences, Shaker Heights, OH, USA
|
|
11:30-11:45 a.m.
|
REFRESHMENTS
|
|
11:45 -12:45 p.m.
|
White Wine Mediated Amelioration of Myocardial Ischemic Reperfusion Injury: Does Color Matter
Samson Mathews Samuel (PhD); Mahesh Thirunavukkarasu; and Professor Nilanjana Maulik (PhD), University of Connecticut Medical Center, Department of Surgery, Molecular Cardiology and Angiogenesis Laboratory, Farmington, Connecticut, USA
|
|
12:45-1:15 p.m.
|
Summary of Baltics Pharma Market for Obesity Products. Alternative for Chemicals - Functional Food
Mykolas Aniunas, Kaunas Medical University, Kaunas, Lithuania
|
|
1:15-2:15 p.m.
|
LUNCH
|
|
|
Chairing: Jairam Vanamala, PhD, Assistent Professor, Bioactive Compounds for Health Laboratory, Department of Food Science and Human Nutrition, Colorado State Univerity, Fort Collins, Colorado, USA
|
|
2:15-3:00 p.m.
|
Honey Versus Sucrose: The Impact on Weight Gain and Biochemical Measures After Short-Term and Long-Term Feeding
Lynne Merran Chepulis, PhD, Honey Research Unit, Department of Biological Sciences, Waikato University, Hamilton, New Zealand
|
|
3:00-3:45 p.m.
|
Designing Functional Foods to Prevent Obesity in Children: The Role of Sensory Issues
Shanon Trueman (Project Analyst), and Coreen Reed Agriculture and Food Science, Nerac, Inc. Tolland, Connecticut USA
|
|
3:45-4:30 p.m.
|
POSTERS PRESENTATION SESSION AND WORKSHOP
|
|
|
Friday, October 17, 2008
|
|
Chairing: Undurti N Das, MD, President of UND Life Sciences, Shaker Heights, OH, USA
|
|
9:30-10:15 a.m.
|
How to Make Money from Food Innovation
Charles J. Brez, Vice President of Nine Sigma, Inc. Cleveland, OH, USA
|
|
10:15-11:00 a.m.
|
Benefits of Amaranth Oil for Diabetic Patients with Obesity
Danik M. Martirosyan, PhD, Founder of Functional Foods Center at D&A Inc., Dallas, USA, Vladimir Zoloedov, MD, Vice Chancellor for Research at Voronej State University, Lida Miroshnichenko, PhD, Voronej, Russia
|
|
11:00-11:15 a.m.
|
REFRESHMENTS
|
|
11:15-12:15 p.m.
|
The Potentiel Use of an Extract of Irvingia Gabonensis in the Management of Obesity and Metabolic Syndrome in Cameroon
Dr. Julius E Oben, Professor, Head of Laboratory of Nutrition and Nutritional Biochemistry, Department of Biochemistry, Faculty of Science, University of Yaounde, Cameroon
|
|
12:00-1:00 p.m.
|
Potential Role of Borreria Hispida in Ameliorating the Risk Factors of Cardiovascular Disease
Hannah R. Vasanthi, PhD, Assistant Professor, Cardiovascular Research Center, University of Connecticut School of Medicine, Farmington, Connecticut, USA, Herbal and Indian Medicine Research Laboratory, Sri Ramachandra University, Chennai, India.
|
|
1:00-2:00 p.m.
|
LUNCH
|
|
Chairing: Charles J. Brez, Vice President of Nine Sigma, Inc. Cleveland, OH, USA
|
|
|
|
2:00-2:45 p.m.
|
Stabilized Rice Bran as a Functional Ingredient for Chronic Diseases
Fatemeh Malekian, PhD, Associate Professor, Food Science and Nutrition, Southern University Agricultural Research and Extension Center, Baton Rouge, LA, USA
|
|
2:45-3:30 p.m.
|
The Effect of Crataegus Extract on Heart Mitochondrial Function.
Jurga Bernatoniene, PhD, Kaunas Medical University, Drug Technology and Social Pharmacy, Kaunas, Lithuania
|
|
3:30-4:30 p.m.
|
POSTERS PRESENTATION SESSION AND WORKSHOP
|
|
Saturday, October 18, 2008
|
|
Chairing: Mykolas Aniunas, Kaunas Medical University, Kaunas, Lithuania
|
|
9:30-10:30 a.m.
|
Obesity-Enhanced Colon Cancer: Functional Food Compounds and their Mechanisms of Action
Jairam Vanamala, PhD, Assistent Professor, Bioactive Compounds for Health Laboratory, Department of Food Science and Human Nutrition, Colorado State Univerity, Fort Collins, Colorado, USA
|
|
10:30-11:30 a.m.
|
Broccoli Protects Heart Through the Activation of Genes of Thioredoxin Superfamily
Subhendu Mukherjee, Hiranmoy Gangopadhyay and Dr. Dipak K. Das, Cardiovascular Research Center, University of Connecticut School of Medicine, Farmington, Connecticut, USA
|
|
11:30-11:45 a.m.
|
REFRESHMENTS
|
|
11:45-12:30 p.m.
|
The Pros and Cons of Pizza Consumption for Obesity
Danik Martirosyan, PhD, Owner of D&A Pizza and Founder of Functional Foods Center, Dallas, TX, USA.
|
|
12:30 p.m.
|
Cytokines and Factors Related with the Activity of Olive Oil Mixture and Obesity
Vicente G. Villarrubia, MD, Epidemiology & Public Health, Director of R&D, BIOAVEDA, Jaén, Spain
|
|
1:00 p.m
|
CONFERENCE CLOSING
Dr. Danik M. Martirosyan - Chairmen of Conference, Functional Foods Center, Dallas, TX, USA
|
|
|
|
Conference Committee
Conference Chairman: Danik M. Martirosyan, PhD, USA
Scientific Program Committee
Laszlo Halmy, MD, PhD, President of Hungarian Society for the Study of Obesity, Hangaria
Michael Hermanussen, MD, PhD, Christian-Albrechts University, Kiel, Germany
Chandan Prasad, PhD, Professor and Chair Department of Nutrition and Food Sciences, Texas Woman's University, USA
International Advisory Committee
Dr. Megh Bhandari, PhD, Agricultural Ministry, Nepal
Dilip Ghosh, PhD, FACN, Regulatory Affairs, Smart Foods Centre, University of Wollongong, Australia
Arunas B. Savitskas, MD, Lead of Department of Drug Technology and Pharmacy at Kaunas Medical University, Lithuania
Sabrina Hamri-Zeghichi, PhD, Equipe Coeur & Nutrition, Faculty of Medicine, Domaine de la Merci, La Tronche Cedex, France
Vicente G. Villarrubia, MD, Epidemiology & Public Health, Director of R&D, BIOAVEDA, Jaén, Spain
Fundraising Committee
Roz Kennon, VP of Marketing and New Products, Ninesigma, USA
|
|
|
PRELIMINARY LIST OF TOPICS
Epidemiology of obesity
The modern mechanisms of obesity
Energy metabolism and obesity
Neurobiological mechanisms of obesity
Microbiological mechanisms of obesity
Pathophysiologic Mechanisms of obesity
Session: Obesity and related diseases
· Type 2 (non-insulin dependent) diabetes
· Cardiovascular diseases
· Cancer of the kidney, endometrium, breast, colon and rectum, esophagus, prostate and gall bladder
· Hyperinsulinemia, insulin resistance, glucose intolerance
· Non-alcoholic fatty liver disease
· Sleep apnea and other respiratory problems
· Pregnancy complications
· Psychological disorders
Session: Contributing factors of obesity
· Energy metabolism
· Food intake
· Modern diet
· Physical activity
· Genetics
Macronutrient influences on weight control
· Dietary fat
· Carbohydrates
· Dietary fiber
· High protein diets
Functional foods for the prevention and treatment of obesity
· Nutrition-based prevention and treatment
· The role of minerals, vitamins, anti-oxidants and phytonutrients in a healthy diet
· Functional foods and prevention
· Functional foods for the treatment of obesity
· Formulating weight control functional foods products:
a) Preclinical research data
b) Evaluation of human experimental data
· Breaking news on functional foods for obesity
· The future of functional foods for obesity and obesity related diseases
|
|
|
|
